Pentasodium diethylenetriamine pentaacetate, DTPA for COVID-19

 Pentasodium diethylenetriamine pentaacetate, DTPA has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed pentasodium diethylenetriamine pentaacetate, DTPA in detail.
Imam et al., Efficacy of pentasodium diethylenetriamine pentaacetate in ameliorating anosmia post COVID-19, American Journal of Otolaryngology, doi:10.1016/j.amjoto.2023.103871